{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:01:17Z","timestamp":1776722477426,"version":"3.51.2"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"DOI":"10.1007\/s12308-026-00690-w","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:05:50Z","timestamp":1774652750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["AIns (insulin) type amyloidosis in a kidney transplant candidate with a newly identified monoclonal gammopathy"],"prefix":"10.1007","volume":"19","author":[{"given":"Carlos","family":"Villarroel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7387-8154","authenticated-orcid":false,"given":"Aaron J.","family":"Wyse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1050-922X","authenticated-orcid":false,"given":"Udit","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2427-6442","authenticated-orcid":false,"given":"Sarah E.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"690_CR1","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.mayocp.2020.06.029","volume":"95","author":"S Dasari","year":"2020","unstructured":"Dasari S, Theis JD, Vrana JA et al (2020) Amyloid typing by mass spectrometry in clinical practice: a comprehensive review of 16,175 samples. Mayo Clin Proc 95:1852\u20131864. https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.029","journal-title":"Mayo Clin Proc"},{"key":"690_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054655","volume":"24","author":"R Goldis","year":"2023","unstructured":"Goldis R, Kaplan B, Kukuy OL et al (2023) Diagnostic challenges and solutions in systemic amyloidosis. Int J Mol Sci 24:4655. https:\/\/doi.org\/10.3390\/ijms24054655","journal-title":"Int J Mol Sci"},{"key":"690_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/13506129.2024.2405948","volume":"31","author":"JN Buxbaum","year":"2024","unstructured":"Buxbaum JN, Eisenberg DS, Fandrich M et al (2024) Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 31:249\u2013256. https:\/\/doi.org\/10.1080\/13506129.2024.2405948","journal-title":"Amyloid"},{"key":"690_CR4","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","volume":"114","author":"JA Vrana","year":"2009","unstructured":"Vrana JA, Gamez JD, Madden BJ et al (2009) Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 114:4957\u20134959. https:\/\/doi.org\/10.1182\/blood-2009-07-230722","journal-title":"Blood"},{"key":"690_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0080-9","volume":"8","author":"MA Gertz","year":"2018","unstructured":"Gertz MA (2018) Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018. Blood Cancer J 8:44. https:\/\/doi.org\/10.1038\/s41408-018-0080-9","journal-title":"Blood Cancer J"},{"key":"690_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ajh.27177","volume":"99","author":"MA Gertz","year":"2024","unstructured":"Gertz MA (2024) Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment. Am J Hematol 99:309\u2013324. https:\/\/doi.org\/10.1002\/ajh.27177","journal-title":"Am J Hematol"},{"key":"690_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/13506129.2022.2031963","volume":"29","author":"A Chiu","year":"2022","unstructured":"Chiu A, Dasari S, Kurtin PJ et al (2022) Bone marrow amyloid: a comprehensive analysis of 1,469 samples, including amyloid type, clinical features, and morphologic distribution. Amyloid 29:156\u2013164. https:\/\/doi.org\/10.1080\/13506129.2022.2031963","journal-title":"Amyloid"},{"key":"690_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14817","volume":"75","author":"A Terre","year":"2021","unstructured":"Terre A, Colombat M, Cez A et al (2021) AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of \u201cmonoclonal gammopathy of inflammatory significance\u201d? Int J Clin Pract 75:e14817. https:\/\/doi.org\/10.1111\/ijcp.14817","journal-title":"Int J Clin Pract"},{"key":"690_CR9","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3324\/haematol.2013.102764","volume":"99","author":"JA Vrana","year":"2014","unstructured":"Vrana JA, Theis JD, Dasari S et al (2014) Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics. Haematologica 99:1239\u20131247. https:\/\/doi.org\/10.3324\/haematol.2013.102764","journal-title":"Haematologica"},{"key":"690_CR10","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/s1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538-548. https:\/\/doi.org\/10.1016\/s1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"key":"690_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0077-4","volume":"8","author":"A Lakshman","year":"2018","unstructured":"Lakshman A, Rajkumar SV, Buadi FK et al (2018) Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria. Blood Cancer J 8:59. https:\/\/doi.org\/10.1038\/s41408-018-0077-4","journal-title":"Blood Cancer J"},{"key":"690_CR12","volume-title":"Haematolymphoid tumours (WHO Classification of Tumours series, 5th ed.; vol. 11)","author":"WHO Classification of Tumours Editorial Board","year":"2024","unstructured":"WHO Classification of Tumours Editorial Board (2024) Haematolymphoid tumours (WHO Classification of Tumours series, <EditionNumber>5th ed.<\/EditionNumber>; vol. 11), 5th ed. International Agency for Research on Cancer, Lyon (France)","edition":"5th ed."},{"key":"690_CR13","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.kint.2025.07.011","volume":"108","author":"N Murakami","year":"2025","unstructured":"Murakami N, Blosser CD, Webber AB et al (2025) Management recommendations for kidney transplantation in patients with plasma cell dyscrasia. Kidney Int 108:780\u2013790. https:\/\/doi.org\/10.1016\/j.kint.2025.07.011","journal-title":"Kidney Int"},{"key":"690_CR14","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.34067\/kid.0004232021","volume":"2","author":"R Lam","year":"2021","unstructured":"Lam R, Lim MA, Dember LM (2021) Suitability for kidney transplantation in AL amyloidosis: a survey study of transplant and amyloidosis physicians. Kidney360 2:1987\u20131997. https:\/\/doi.org\/10.34067\/kid.0004232021","journal-title":"Kidney360"},{"key":"690_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/13506129.2013.876984","volume":"21","author":"A D'Souza","year":"2014","unstructured":"D\u2019Souza A, Theis JD, Vrana JA, Dogan A (2014) Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration. Amyloid 21:71\u201375. https:\/\/doi.org\/10.3109\/13506129.2013.876984","journal-title":"Amyloid"},{"key":"690_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2025.2588807","author":"D Varghese","year":"2025","unstructured":"Varghese D, Munir KM, Davis SN (2025) What is our current understanding of insulin-derived amyloidosis? Expert Opin Drug Saf. https:\/\/doi.org\/10.1080\/14740338.2025.2588807","journal-title":"Expert Opin Drug Saf"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00690-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-026-00690-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00690-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:05:51Z","timestamp":1774652751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-026-00690-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["690"],"URL":"https:\/\/doi.org\/10.1007\/s12308-026-00690-w","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was not supported by any funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"SE Gibson is an advisory board member for Roche Diagnostics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of retrospective study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This is a retrospective study, and only existing pathology slides and radiology images were utilized. For this type of study, informed consent is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"No patient recruitment or communication was needed for this study. No identifiable patient information or image was included. For this type of study, consent for publication is not required.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"12"}}